The market expects Invitae (NVTA) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2021. This widely-known consensus outlook is ...
Update 3:10pm: Adds Invitae shares were halted for news pending. The genetic-testing company is working with FTI Consulting and law firm Kirkland & Ellis to explore strategic alternatives, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results